Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline.
about
From rapalogs to anti-aging formula.Yeast as a tool to select inhibitors of the cullin deneddylating enzyme Csn5.Application of surface plasmon resonance imaging to monitoring G protein-coupled receptor signaling and its modulation in a heterologous expression system.Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes.Aspirin, lysine, mifepristone and doxycycline combined can effectively and safely prevent and treat cancer metastasis: prevent seeds from gemmating on soil.Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cellsDoxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.Roles of Multifunctional COP9 Signalosome Complex in Cell Fate and Implications for Drug Discovery.Mitochondrial dysfunction and potential anticancer therapy.Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer.Repurposing of FDA-approved drugs against cancer - focus on metastasis.Doxycycline: new tricks for an old drug.Doxycycline and therapeutic targeting of the DNA damage response in cancer cells: old drug, new purpose.Silencing heme oxygenase-1 increases the sensitivity of ABC-DLBCL cells to histone deacetylase inhibitor in vitro and in vivo.Pro-apoptotic effect of doxycycline and hydroxychloroquine on B-cell lymphoma induced by C. burnetii.Metabolic Abnormalities Detected in Phase II Evaluation of Doxycycline in Dogs with Multicentric B-Cell Lymphoma.Mitochondria as oncotarget: a comparison between the tetracycline analogs doxycycline and COL-3
P2860
Q33829205-6A4D9DF6-2E2E-421B-8057-BC4866153416Q35974190-42C67ACB-6646-4401-ABF8-5B00EAFFC0AEQ35986555-CD37FC7B-7D70-4DD6-ADA2-6A21D5C5EECFQ36274684-D1B84CAC-C2E7-47DE-9DC4-56B9C72C67E6Q36405748-650B24B1-A496-4934-83A7-6BE10B2306EEQ36546288-39B66937-BC63-40ED-B6BB-23F57D90E6C3Q36562128-6AD1AF0C-C71A-4A59-A64F-956D3A46BB19Q37689051-8AE07E1E-4A5A-41AC-A1C4-A8C4438AD3CBQ39015104-D2AF2749-EA18-41AC-9413-EA40669ABD22Q39418003-AFD09621-AF65-4A89-AEBC-D29EE58E0137Q42290467-3EF5896D-D945-4FD7-B784-32B9E9E9B474Q42523325-D8081153-FA42-438B-A268-555FF77E2299Q43184207-5B039A7D-56A6-4572-A83A-DC59D1EC8A42Q43242535-1698417C-7018-4DD5-ABA8-C904FB27843BQ44315979-3B510BFD-FC9A-4A10-A0B6-1BEFC05B92ACQ49269359-C84BA29A-D69A-4B32-90CB-0DBF8AEB78A6Q55058455-A979BC11-2AEC-48AA-AEC2-445C73C2B0B2Q58554018-DB77899C-1E76-4EBE-BDC5-8124805A6093
P2860
Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inhibition of COP9-signalosome ...... cell lymphomas by doxycycline.
@ast
Inhibition of COP9-signalosome ...... cell lymphomas by doxycycline.
@en
type
label
Inhibition of COP9-signalosome ...... cell lymphomas by doxycycline.
@ast
Inhibition of COP9-signalosome ...... cell lymphomas by doxycycline.
@en
prefLabel
Inhibition of COP9-signalosome ...... cell lymphomas by doxycycline.
@ast
Inhibition of COP9-signalosome ...... cell lymphomas by doxycycline.
@en
P2093
P2860
P356
P1433
P1476
Inhibition of COP9-signalosome ...... cell lymphomas by doxycycline.
@en
P2093
Brian Poligone
Carla Casulo
Craig Jordan
David Oleksyn
George Compitello
Hartmut Land
Jiyong Zhao
Joel L Shapiro
Jonathan W Friedberg
P2860
P304
14796-14813
P356
10.18632/ONCOTARGET.4193
P407
P577
2015-06-01T00:00:00Z